Page last updated: 2024-08-25

zoledronic acid and Spinal Cord Neoplasms

zoledronic acid has been researched along with Spinal Cord Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, JW; Chen, SM; Hsieh, LL; Li, YY; Yeh, KY1

Other Studies

1 other study(ies) available for zoledronic acid and Spinal Cord Neoplasms

ArticleYear
Low-dose zoledronic acid reduces spinal cord metastasis in pulmonary adenocarcinoma with neuroendocrine differentiation.
    Anti-cancer drugs, 2012, Volume: 23, Issue:9

    Topics: Animals; Antineoplastic Agents; Carcinoma, Neuroendocrine; Cell Differentiation; Cell Line, Tumor; Cloning, Molecular; Diphosphonates; Dose-Response Relationship, Drug; Flow Cytometry; Gene Knockdown Techniques; Green Fluorescent Proteins; Imidazoles; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neoplasm Transplantation; Neural Cell Adhesion Molecules; RNA, Small Interfering; Spinal Cord Neoplasms; Transfection; Zoledronic Acid

2012